TABLE 4.
Per-protocol analysis
Parameter | EPA-rich fish oil (n = 31), mean (SD) | DHA-rich fish oil (n = 33), mean (SD) | Placebo (n = 32), mean (SD) | Significance |
---|---|---|---|---|
BDI visit 2 | 7.9 (3.7) | 6.5 (4.7) | 6.3 (4.1) | .29a |
BDI visit 3 | 7.4 (5.0) | 5.9 (4.9) | 7.2 (5.2) | .51a |
BDI visit 5 | 6.6 (5.2) | 5.1 (4.4) | 6.2 (6.5) | .56a |
ANOVA, analysis of variance; BDI, Beck Depression Inventory; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; SD, standard deviation.
One-way ANOVA controlling for BDI score at enrollment.